NewEdge Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$120	–	3834
2023 Q3	$120	Hold	2	–	–	﹤0.01%	3357
2023 Q2	$144	Sell	2 -329	-99%	-$23.7K	﹤0.01%	3400
2023 Q1	$24.3K	Sell	331 -10	-3%	-$736	﹤0.01%	2268
2022 Q4	$556	Buy	+341	New	+$556	﹤0.01%	3150